PPA2 and cardiomyopathy: Despite what we know of the biology of PPA2, admittedly we do not have a true understanding of how the cellular deficits lead to organ‐level dysfunctions that most likely leads to death, cardiomyopathy, lethal arrhythmias, or predeliction to a rapidly fatal myocarditis.